Naomi Kanazawa
- Neurology top 5%
- Autoimmune Neurological Disorders and Treatments 21
- Peripheral Neuropathies and Disorders 13
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders 9
-
- Hereditary Neurological Disorders 4
- Psychiatry and Mental health top 10%
- Rheumatology top 10%
- Folate and B Vitamins Research 6
-
- RNA regulation and disease 11
- RNA Research and Splicing 8
-
- Polyomavirus and related diseases 4
Naomi Kanazawa
54 papers receiving 757 citations
Peers
Comparison fields: 5 of 65
- Neurology 342
- Clinical Biochemistry 100
- Cellular and Molecular Neuroscience 138
- Psychiatry and Mental health 110
- Rheumatology 91
Countries citing papers authored by Naomi Kanazawa
This map shows the geographic impact of Naomi Kanazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomi Kanazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomi Kanazawa more than expected).
Fields of papers citing papers by Naomi Kanazawa
This network shows the impact of papers produced by Naomi Kanazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomi Kanazawa. The network helps show where Naomi Kanazawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Naomi Kanazawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 7 | |
| 4 | 2021 | 1 | |
| 5 | 2020 | 5 | |
| 6 | 2019 | 8 | |
| 7 | 2018 | 22 | |
| 8 | 2010 | 44 | |
| 9 | Plasma orexin-A levels in patients with migraine | 2008 | 2 |
| 10 | 2007 | 26 | |
| 11 | 2007 | 11 | |
| 12 | 2006 | 5 | |
| 13 | Distribution of transient receptor potential vanilloid 1(TRPV1)in the trigeminovascular system of the rat | 2005 | 1 |
| 14 | 2005 | 9 | |
| 15 | 2004 | 23 | |
| 16 | 2003 | 27 | |
| 17 | 2002 | 12 | |
| 18 | 2000 | 31 | |
| 19 | 1998 | 3 | |
| 20 | Clinical and Immunological Studies of Polyneuropathy Associated with Monoclonal Gammopathy | 1994 | 1 |
About Naomi Kanazawa
Naomi Kanazawa is a scholar working on Neurology, Clinical Biochemistry and Sensory Systems, having authored 55 papers that have together received 781 indexed citations. Recurring topics across this work include Autoimmune Neurological Disorders and Treatments (21 papers), Peripheral Neuropathies and Disorders (13 papers), RNA regulation and disease (11 papers), Metabolism and Genetic Disorders (9 papers), RNA Research and Splicing (8 papers), Folate and B Vitamins Research (6 papers), Hereditary Neurological Disorders (4 papers) and Polyomavirus and related diseases (4 papers). The work is most often cited by research in Neurology (342 citations), Clinical Biochemistry (100 citations) and Cellular and Molecular Neuroscience (138 citations). Naomi Kanazawa has collaborated with scholars based in Japan, United States and Spain. Frequent co-authors include Seiichi Tsujino, Eiji Kitamura, Takahiro Iizuka, Kazutoshi Nishiyama, Toyokazu Saito, Juntaro Kaneko, Mieko Ogino, Naomi Tominaga, Junichi Hamada and Ray Masuda. Their work appears in journals such as Neurology, Annals of Neurology and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.